Question 1

How many shares of TNGX does JACOBS LEVY EQUITY MANAGEMENT, INC own?

Accepted Answer

JACOBS LEVY EQUITY MANAGEMENT, INC previously held 0 shares of TNGX (Tango Therapeutics, Inc.) before exiting the position in 2025-Q3.

Question 2

What is JACOBS LEVY EQUITY MANAGEMENT, INC's TNGX position worth?

Accepted Answer

JACOBS LEVY EQUITY MANAGEMENT, INC's TNGX position was last reported at $0 in 2025-Q3 before the exit.

Question 3

Is JACOBS LEVY EQUITY MANAGEMENT, INC buying or selling TNGX?

Accepted Answer

In 2025-Q3, JACOBS LEVY EQUITY MANAGEMENT, INC exited their TNGX position entirely (-100.0% change in shares).

Question 4

When did JACOBS LEVY EQUITY MANAGEMENT, INC first buy TNGX?

Accepted Answer

Based on available 13F filings, JACOBS LEVY EQUITY MANAGEMENT, INC first reported a position in TNGX in 2022-Q3. They have held the position across 12 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q3 Latest	Exited	0	-100.0%	$0	0.0%	$8.44	0
2025-Q2	Decreased	218,779	-70.3%	$1.1M	0.0%	$5.01	0
2025-Q1	Increased	737,955	+42.6%	$1M	0.0%	$1.47	34
2024-Q4	New	517,426	-	$1.6M	0.0%	$3.10	35
2024-Q2	Exited	0	-100.0%	$0	0.0%	$8.58	0
2024-Q1	Decreased	21,338	-61.8%	$169,424	0.0%	$7.94	0
2023-Q4	Decreased	55,814	-61.1%	$552,559	0.0%	$9.90	0
2023-Q3	Decreased	143,481	-55.0%	$1.6M	0.0%	$11.26	0
2023-Q2	Decreased	318,776	-21.4%	$1.1M	0.0%	$3.26	0
2023-Q1	Increased	405,565	+17.1%	$1.6M	0.0%	$3.92	30
2022-Q4	Increased	346,471	+0.2%	$2.5M	0.0%	$7.25	26
2022-Q3	New	345,923	-	$1.3M	0.0%	$3.60	35

TNGX12 quarters

TNGX
12 quarters